Plasma Hemopexin ameliorates murine spinal cord injury by switching microglia from the M1 state to the M2 state

[1]  Yanbo Zhang,et al.  Minocycline Ameliorates Depressive-Like Behavior and Demyelination Induced by Transient Global Cerebral Ischemia by Inhibiting Microglial Activation , 2019, Front. Pharmacol..

[2]  Ann Smith,et al.  What Is Next in This “Age” of Heme-Driven Pathology and Protection by Hemopexin? An Update and Links with Iron † , 2019, Pharmaceuticals.

[3]  S. Okada,et al.  Tranexamic acid reduces heme cytotoxicity via the TLR4/TNF axis and ameliorates functional recovery after spinal cord injury , 2019, Journal of Neuroinflammation.

[4]  Lianyong Wang,et al.  Polycaprolactone electrospun fiber scaffold loaded with iPSCs-NSCs and ASCs as a novel tissue engineering scaffold for the treatment of spinal cord injury , 2018, International journal of nanomedicine.

[5]  M. Colonna,et al.  Microglia Function in the Central Nervous System During Health and Neurodegeneration. , 2017, Annual review of immunology.

[6]  Shaoqun Zeng,et al.  A distinct entorhinal cortex to hippocampal CA1 direct circuit for olfactory associative learning , 2017, Nature Neuroscience.

[7]  R. Colvin,et al.  Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells , 2016, Circulation.

[8]  S. Reddy,et al.  Apolipoprotein E−/− Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[9]  F. Zipp,et al.  Microglia–blood vessel interactions: a double-edged sword in brain pathologies , 2016, Acta Neuropathologica.

[10]  A. Zuercher,et al.  Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease. , 2016, Blood.

[11]  Cheng He,et al.  Neuroprotective effects of nitidine against traumatic CNS injury via inhibiting microglia activation , 2015, Brain, Behavior, and Immunity.

[12]  J. Berwick,et al.  LRP-1-mediated intracellular antibody delivery to the Central Nervous System , 2015, Scientific Reports.

[13]  Z. Xiang,et al.  MSX3 Switches Microglia Polarization and Protects from Inflammation-Induced Demyelination , 2015, The Journal of Neuroscience.

[14]  W. Young,et al.  Macrophages in spinal cord injury: Phenotypic and functional change from exposure to myelin debris , 2015, Glia.

[15]  S. Doré,et al.  Deletion of the hemopexin or heme oxygenase-2 gene aggravates brain injury following stroma-free hemoglobin-induced intracerebral hemorrhage , 2015, Journal of Neuroinflammation.

[16]  L. Facci,et al.  Toll-Like Receptors 2, -3 and -4 Prime Microglia but not Astrocytes Across Central Nervous System Regions for ATP-Dependent Interleukin-1β Release , 2014, Scientific Reports.

[17]  M. Gaestel,et al.  TNF and Increased Intracellular Iron Alter Macrophage Polarization to a Detrimental M1 Phenotype in the Injured Spinal Cord , 2014, Neuron.

[18]  M. Bozza,et al.  Heme on innate immunity and inflammation , 2014, Front. Pharmacol..

[19]  Rafael J. Yáñez-Muñoz,et al.  Large-Scale Chondroitin Sulfate Proteoglycan Digestion with Chondroitinase Gene Therapy Leads to Reduced Pathology and Modulates Macrophage Phenotype following Spinal Cord Contusion Injury , 2014, The Journal of Neuroscience.

[20]  M. Fehlings,et al.  Characterization of vascular disruption and blood-spinal cord barrier permeability following traumatic spinal cord injury. , 2014, Journal of neurotrauma.

[21]  L. Silengo,et al.  Acute-Phase Protein Hemopexin Is a Negative Regulator of Th17 Response and Experimental Autoimmune Encephalomyelitis Development , 2013, The Journal of Immunology.

[22]  H. Bock,et al.  Low density receptor-related protein 1 (LRP1) promotes anti-inflammatory phenotype in murine macrophages , 2013, Cell and Tissue Research.

[23]  Tracy J. Yuen,et al.  M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination , 2013, Nature Neuroscience.

[24]  L. Xiong,et al.  Hemopexin induces neuroprotection in the rat subjected to focal cerebral ischemia , 2013, BMC Neuroscience.

[25]  T. Miyata,et al.  A Small Molecule Inhibitor to Plasminogen Activator Inhibitor 1 Inhibits Macrophage Migration , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[26]  A. Shah,et al.  ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions , 2013, Proceedings of the National Academy of Sciences.

[27]  A. Faissner,et al.  A LewisX Glycoprotein Screen Identifies the Low Density Lipoprotein Receptor-related Protein 1 (LRP1) as a Modulator of Oligodendrogenesis in Mice* , 2013, The Journal of Biological Chemistry.

[28]  A. Aguzzi,et al.  Microglia: Scapegoat, Saboteur, or Something Else? , 2013, Science.

[29]  K. Tracey,et al.  Identification of Hemopexin as an Anti-Inflammatory Factor That Inhibits Synergy of Hemoglobin with HMGB1 in Sterile and Infectious Inflammation , 2012, The Journal of Immunology.

[30]  K. Suk,et al.  Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity , 2012, Journal of Neuroinflammation.

[31]  P. Popovich,et al.  Deficient CX3CR1 Signaling Promotes Recovery after Mouse Spinal Cord Injury by Limiting the Recruitment and Activation of Ly6Clo/iNOS+ Macrophages , 2011, The Journal of Neuroscience.

[32]  S. David,et al.  Repertoire of microglial and macrophage responses after spinal cord injury , 2011, Nature Reviews Neuroscience.

[33]  A. Vercelli,et al.  A Role for Hemopexin in Oligodendrocyte Differentiation and Myelin Formation , 2011, PloS one.

[34]  T. Yamashita,et al.  RGMa modulates T cell responses and is involved in autoimmune encephalomyelitis , 2011, Nature Medicine.

[35]  Xuefeng Zhang,et al.  Increased striatal injury and behavioral deficits after intracerebral hemorrhage in hemopexin knockout mice. , 2011, Journal of neurosurgery.

[36]  M. Crawford,et al.  Assessing Spinal Axon Regeneration and Sprouting in Nogo-, MAG-, and OMgp-Deficient Mice , 2010, Neuron.

[37]  S. Strittmatter,et al.  MAG and OMgp Synergize with Nogo-A to Restrict Axonal Growth and Neurological Recovery after Spinal Cord Trauma , 2010, The Journal of Neuroscience.

[38]  N. Morello,et al.  Heme scavenging and the other facets of hemopexin. , 2010, Antioxidants & redox signaling.

[39]  Jessica K. Alexander,et al.  Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord , 2009, The Journal of Neuroscience.

[40]  J. Cavaillon,et al.  Hemopexin down‐regulates LPS‐induced proinflammatory cytokines from macrophages , 2009, Journal of leukocyte biology.

[41]  Steffen Jung,et al.  Infiltrating Blood-Derived Macrophages Are Vital Cells Playing an Anti-inflammatory Role in Recovery from Spinal Cord Injury in Mice , 2009, PLoS medicine.

[42]  S. Doré,et al.  Heme–Hemopexin Complex Attenuates Neuronal Cell Death and Stroke Damage , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[43]  M. Stoltenberg,et al.  Lack of Plasma Protein Hemopexin Dampens Mercury-Induced Autoimmune Response in Mice1 , 2008, The Journal of Immunology.

[44]  P. Popovich,et al.  Can the immune system be harnessed to repair the CNS? , 2008, Nature Reviews Neuroscience.

[45]  W. Tetzlaff,et al.  A graded forceps crush spinal cord injury model in mice. , 2008, Journal of neurotrauma.

[46]  D. Lawrence,et al.  Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit. , 2007, Blood.

[47]  David A Ramsay,et al.  The cellular inflammatory response in human spinal cords after injury. , 2006, Brain : a journal of neurology.

[48]  H. Okano,et al.  A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord , 2006, Nature Medicine.

[49]  D. Burke,et al.  The Louisville Swim Scale: a novel assessment of hindlimb function following spinal cord injury in adult rats. , 2006, Journal of neurotrauma.

[50]  Aileen J Anderson,et al.  Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. , 2006, Journal of neurotrauma.

[51]  R. Hintzen,et al.  Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. , 2006, Brain : a journal of neurology.

[52]  P. Højrup,et al.  Identification of the receptor scavenging hemopexin-heme complexes. , 2005, Blood.

[53]  E. J. Green,et al.  Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury , 2005, The Journal of experimental medicine.

[54]  S. Goldman,et al.  P2X7 receptor inhibition improves recovery after spinal cord injury , 2004, Nature Medicine.

[55]  M. Tuszynski,et al.  Combinatorial Therapy with Neurotrophins and cAMP Promotes Axonal Regeneration beyond Sites of Spinal Cord Injury , 2004, The Journal of Neuroscience.

[56]  M. Essig,et al.  Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury , 2004, Nature Medicine.

[57]  Ngan B. Doan,et al.  Reactive Astrocytes Protect Tissue and Preserve Function after Spinal Cord Injury , 2004, The Journal of Neuroscience.

[58]  D. Lawrence,et al.  Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. , 2003, The Journal of clinical investigation.

[59]  Joseph F. Clark,et al.  Heme and Iron Metabolism: Role in Cerebral Hemorrhage , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[60]  J. Delanghe,et al.  Hemopexin: a review of biological aspects and the role in laboratory medicine. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[61]  L. Silengo,et al.  Defective recovery and severe renal damage after acute hemolysis in hemopexin-deficient mice. , 1999, Blood.

[62]  Stephen B. Dunnett,et al.  Characterization of Progressive Motor Deficits in Mice Transgenic for the Human Huntington’s Disease Mutation , 1999, The Journal of Neuroscience.

[63]  N. Bertrand,et al.  Changes in expression and localization of hemopexin and its transcripts in injured nervous system: a comparison of central and peripheral tissues , 1997, Neuroscience.

[64]  L. Noble,et al.  Distribution and time course of protein extravasation in the rat spinal cord after contusive injury , 1989, Brain Research.

[65]  B. Allinquant,et al.  [Electro-immunodiffusion of cerebrospinal fluid proteins. Determination of 2 -HS, ceruloplasmin, - 1A - 1C , hemopexin and IgA]. , 1971, Clinica chimica acta; international journal of clinical chemistry.